Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain
{{output}}
Background: Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe. ... ...
